Evidence map›Paper›PMID 21812108›Full record

ReviewMolecular nutrition & food research2011

The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling.

Charles R Myers, Judith M Myers, Timothy D Kufahl, Rachel Forbes, Adam Szadkowski

Abstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Disorders of Redox Homeostasis and Its Importance in Acrolein Toxicity.International journal of molecular sciences · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecular mechanisms of acrolein toxicity: relevance to human disease.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charles R MyersDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. cmyers@mcw.edu
Judith M Myers
Timothy D Kufahl
Rachel Forbes
Adam Szadkowski
Medical College of Wisconsin · US

Funding

Human Lung Chromium Toxicity: Role of cytochrome b5R01ES012707 · NIEHS · MEDICAL COLLEGE OF WISCONSIN · PI MYERS, CHARLES R · 2004 to 2007
$1.3M
Human Lung Chromium Toxicity: Oxidant StressR56ES012707 · NIEHS · MEDICAL COLLEGE OF WISCONSIN · PI MYERS, CHARLES R · 2010 to 2010
$228k
NIEHS NIH HHS ES012707NIEHS NIH HHS R01 ES012707NIEHS NIH HHS R56 ES012707
6 · The paper itself

Abstract

The reactive aldehyde acrolein is a ubiquitous environmental pollutant and is also generated endogenously. It is a strong electrophile and reacts rapidly with nucleophiles including thiolates. This review focuses on the effects of acrolein on thioredoxin reductase (TrxR) and thioredoxin (Trx), which are major regulators of intracellular protein thiol redox balance. Acrolein causes irreversible effects on TrxR and Trx, which are consistent with the formation of covalent adducts to selenocysteine and cysteine residues that are key to their activity. TrxR and Trx are more sensitive than some other redox-sensitive proteins, and their prolonged inhibition could disrupt a number of redox-sensitive functions in cells. Among these effects are the oxidation of peroxiredoxins and the activation of apoptosis signal regulating kinase (ASK1). ASK1 promotes MAP kinase activation, and p38 activation contributes to apoptosis and a number of other acrolein-induced stress responses. Overall, the disruption of the TrxR/Trx system by acrolein could be significant early and prolonged events that affect many aspects of redox-sensitive signaling and oxidant stress.

Indexed as

AcroleinEndothelium, VascularEnzyme InhibitorsHumansMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein KinasesPeroxiredoxinsSelenocysteineSignal TransductionSulfhydryl CompoundsThioredoxin-Disulfide ReductaseThioredoxinsAcroleinEnzyme InhibitorsMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein KinasesPeroxiredoxinsSelenocysteineSulfhydryl CompoundsThioredoxin-Disulfide ReductaseThioredoxins

Identifiers

PMID21812108
PMCPMC3517082
OpenAlexW1982091641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.